Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EyeGuide is a private U.S. health technology and bioinformatics company focused on objective brain health monitoring using eye-tracking. Its main commercial product, EyeGuide Focus, is a rapid 10-second software-and-hardware test that captures and analyzes eye-movement data to assess visual attention and support wellness monitoring. The company markets its solution for use in sports, schools, healthcare, senior living, workplaces, military settings, and research environments. EyeGuide appears to operate as a commercial digital health and medical device company rather than a therapeutics developer, with its value centered on patented eye-tracking technology, data analytics, and longitudinal monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EyeGuide.